Comments on: What’s in a Name? Alex Berenson (the crusading reporter) vs. Bradford Berenson (the high-powered attorney)

By: A "Responsible Communication" About Reckless Canadian Journalism : Starkman & Associates

Wed, 06 Jan 2010 21:42:32 +0000

[...] New York Times reporter Alex Berenson is representative of the moral compass of journalists who remain in the profession: Having orchestrated a highly dubious scheme to gain access to court-sealed documents relating to the controversial antipsychotic drug Zyprexa, Mr. Berenson then balked about publishing a story when one of his cohorts insisted on making the documents widely available to serve the public good. Faced with a choice of serving the public interest or promoting their own, I sadly suspect most U.S. reporters would follow Berenson’s lead. (An outline of Berenson’s largely unknown antics can be found here and here.) [...]

By: Without Fear or Favor, Alex Berenson, Dr. David Egilman, Eli Lilly Zyprexa, New York Times Ethics : Starkman & Associates

Thu, 28 May 2009 05:02:55 +0000

[...] What’s in a Name? Alex Berenson vs. Bradford Berenson [...]

By: Pete Vilinsky

Pete Vilinsky — Wed, 06 Feb 2008 15:53:40 +0000

I think some more attention should be applied to how Alex Berenson’s email address got there in the first place. I might speculate it could be because someone at that law firm has a conscience wanting the public to know what is really going on. Zyprexa, as well as a whole host of other antidipressants and other psychiatric pharmaceuticals is very dangerous, for both on and off label usages.